These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24979756)

  • 1. Hepatic tissue environment in NEMO-deficient mice critically regulates positive selection of donor cells after hepatocyte transplantation.
    Kaldenbach M; Cubero FJ; Erschfeld S; Liedtke C; Trautwein C; Streetz K
    PLoS One; 2014; 9(6):e100786. PubMed ID: 24979756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
    Cubero FJ; Zhao G; Nevzorova YA; Hatting M; Al Masaoudi M; Verdier J; Peng J; Schaefer FM; Hermanns N; Boekschoten MV; Grouls C; Gassler N; Kiessling F; Muller M; Davis RJ; Liedtke C; Trautwein C
    J Hepatol; 2015 Jan; 62(1):140-9. PubMed ID: 25173965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Toll-like receptor 9 protects from hepatocellular carcinoma in murine models of chronic liver disease.
    Hatten H; Colyn L; Volkert I; Gaßler N; Lammers T; Hofmann U; Hengstler JG; Schneider KM; Trautwein C
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167321. PubMed ID: 38943920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MyD88-dependent signaling in non-parenchymal cells promotes liver carcinogenesis.
    Mohs A; Kuttkat N; Otto T; Youssef SA; De Bruin A; Trautwein C
    Carcinogenesis; 2020 Apr; 41(2):171-181. PubMed ID: 30770929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
    Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
    Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.
    Ehlken H; Krishna-Subramanian S; Ochoa-Callejero L; Kondylis V; Nadi NE; Straub BK; Schirmacher P; Walczak H; Kollias G; Pasparakis M
    Cell Death Differ; 2014 Nov; 21(11):1721-32. PubMed ID: 24971483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.
    Kondylis V; Polykratis A; Ehlken H; Ochoa-Callejero L; Straub BK; Krishna-Subramanian S; Van TM; Curth HM; Heise N; Weih F; Klein U; Schirmacher P; Kelliher M; Pasparakis M
    Cancer Cell; 2015 Nov; 28(5):582-598. PubMed ID: 26555174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.
    Luedde T; Beraza N; Kotsikoris V; van Loo G; Nenci A; De Vos R; Roskams T; Trautwein C; Pasparakis M
    Cancer Cell; 2007 Feb; 11(2):119-32. PubMed ID: 17292824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes.
    Kaldenbach M; Giebeler A; Tschaharganeh DF; Erschfeld S; Wasmuth HE; Dolle L; Floege J; Trautwein C; Streetz KL
    Gut; 2012 Aug; 61(8):1209-18. PubMed ID: 22287599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
    Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
    Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
    Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
    Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic parenchymal replacement in mice by transplanted allogeneic hepatocytes is facilitated by bone marrow transplantation and mediated by CD4 cells.
    Streetz KL; Doyonnas R; Grimm D; Jenkins DD; Fuess S; Perryman S; Lin J; Trautwein C; Shizuru J; Blau H; Sylvester KG; Kay MA
    Hepatology; 2008 Feb; 47(2):706-18. PubMed ID: 18220289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
    Beraza N; Malato Y; Sander LE; Al-Masaoudi M; Freimuth J; Riethmacher D; Gores GJ; Roskams T; Liedtke C; Trautwein C
    J Exp Med; 2009 Aug; 206(8):1727-37. PubMed ID: 19635861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gab1 in livers with persistent hepatocyte apoptosis has an antiapoptotic effect and reduces chronic liver injury, fibrosis, and tumorigenesis.
    Mizutani N; Hikita H; Saito Y; Myojin Y; Sato K; Urabe M; Kurahashi T; Shiode Y; Sakane S; Murai K; Nozaki Y; Kodama T; Sakamori R; Yoshida Y; Tatsumi T; Takehara T
    Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G958-G968. PubMed ID: 33787344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein 130-dependent pathways in host hepatocytes are important for liver repopulation in mice.
    Tschaharganeh DF; Kaldenbach M; Erschfeld S; Tischendorf JJ; Trautwein C; Streetz KL
    Liver Transpl; 2010 Jan; 16(1):23-32. PubMed ID: 20035522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
    Jiang L; Li JG; Lan L; Wang YM; Mao Q; You JP
    Transplant Proc; 2010 Nov; 42(9):3773-8. PubMed ID: 21094855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-κB essential modifier is required for hepatocyte proliferation and the oval cell reaction after partial hepatectomy in mice.
    Malato Y; Ehedego H; Al-Masaoudi M; Cubero FJ; Bornemann J; Gassler N; Liedtke C; Beraza N; Trautwein C
    Gastroenterology; 2012 Dec; 143(6):1597-1608.e11. PubMed ID: 22922425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted deletion of ER chaperone GRP94 in the liver results in injury, repopulation of GRP94-positive hepatocytes, and spontaneous hepatocellular carcinoma development in aged mice.
    Chen WT; Ha D; Kanel G; Lee AS
    Neoplasia; 2014 Aug; 16(8):617-26. PubMed ID: 25220589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Dicer1 impairs hepatocyte survival and leads to chronic inflammation and progenitor cell activation.
    Lu XF; Zhou YJ; Zhang L; Ji HJ; Li L; Shi YJ; Bu H
    World J Gastroenterol; 2015 Jun; 21(21):6591-603. PubMed ID: 26074697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.